evismo in the final of the Swiss Medtech Award 2025

We are delighted that evismo has been nominated as one of three finalists for the prestigious Swiss Medtech Award 2025.

In addition to evismo, the companies Bonebridge and QUMEA are in the race for the coveted award for innovation and entrepreneurial excellence in the Swiss medical technology industry. 

evismo stands for intelligent remote diagnostics in the areas of heart, sleep and stress. Since 2018, we have been offering GP practices and specialists innovative diagnostic services such as CardioFlex, RespiFlex and StressCheck to detect cardiac arrhythmia, sleep apnoea, stress and burnout at an early stage. More than 1,500 medical professionals already rely on our technologies.

The company QUMEA fom Solothurn, which was also nominated, offers AI-based prevention technology to increase patient safety. Their solution uses an anonymous 3D radar sensor that analyses patient movement patterns and informs nursing staff of risks at an early stage.

Bonebridge from Zug, the third finalist, has been developing high-quality implants for the treatment of bone fractures since 2018. Their products are characterised by simple clinical application and high quality and are developed in close collaboration with clinics worldwide.

The winner of the coveted trophy and the prize money of CHF 50,000 will be announced on Swiss Medtech Day on 25 June in Bern. We are proud to be honoured alongside these inspiring companies for our contributions to improving patient care.

More information about the finalists and the award in the article StartupTicker.


Diagnose of sleep apnea directly in your general practitioner's office
While evismo brings the cardiologist into the general practitioner's office with CardioFlex, we now offer the sleep specialist remotely with RespiFlex.